0001127602-22-019721.txt : 20220725 0001127602-22-019721.hdr.sgml : 20220725 20220725142402 ACCESSION NUMBER: 0001127602-22-019721 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220721 FILED AS OF DATE: 20220725 DATE AS OF CHANGE: 20220725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NABEL ELIZABETH G CENTRAL INDEX KEY: 0001619929 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39348 FILM NUMBER: 221102837 MAIL ADDRESS: STREET 1: BRIGHAM AND WOMEN'S HOSPITAL STREET 2: 75 FRANCIS ST CITY: BOSTON STATE: MA ZIP: 02115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Accolade, Inc. CENTRAL INDEX KEY: 0001481646 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 432117836 STATE OF INCORPORATION: DE FISCAL YEAR END: 0228 BUSINESS ADDRESS: STREET 1: 660 W. GERMANTOWN PIKE SUITE 500 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: 347-574-3820 MAIL ADDRESS: STREET 1: 660 W. GERMANTOWN PIKE SUITE 500 CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 FORMER COMPANY: FORMER CONFORMED NAME: Accolade LLC DATE OF NAME CHANGE: 20100121 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-07-21 0001481646 Accolade, Inc. ACCD 0001619929 NABEL ELIZABETH G C/O ACCOLADE, INC. 1201 THIRD AVENUE, SUITE 1700 SEATTLE WA 98101 1 Common Stock 2022-07-21 4 M 0 2659 A 3005 D Restricted Stock Units 2022-07-21 4 M 0 2659 D Common Stock 2659 0 D Each Restricted Stock Unit ("RSU") converted into one share of the Issuer's common stock. Each RSU represents the contingent right to receive one share of Common Stock upon vesting of the RSU. The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) the one year anniversary measured from the date of grant, each subject to continued service as a director through each applicable vesting date. /s/ Richard Eskew, Attorney-in-Fact 2022-07-25